Table 2 Medication utilization of patients with COPD, classified according to the presence of GERD
COPD with GERD (n= 39,987) | COPD without GERD (n= 101,070) | |||
|---|---|---|---|---|
No. | (%) | No. | (%) | |
ICS | 6,439 | (8.8) | 12,734 | (7.7) |
ICS/LABA | 14,436 | (19.6) | 33,593 | (20.3) |
LAMA | 11,760 | (16.0) | 28,529 | (17.2) |
LABA | 35 | (0.0) | 79 | (0.0) |
LTRA | 11,468 | (15.6) | 23,158 | (14.0) |
OCS | 24,031 | (32.7) | 51,421 | (31.0) |
SAMA | 7,763 | (10.6) | 16,850 | (10.2) |
SABA | 14,596 | (19.9) | 32,904 | (19.9) |
SABA/SAMA | 1,048 | (1.4) | 2,603 | (1.6) |
Oral beta-2 agonists | 23,530 | (32.0) | 55,856 | (33.7) |
Theophylline | 33,859 | (46.0) | 83,688 | (50.5) |